Concepedia

Srdjan Stankovic

SS

15

Publications

578

Citations

13

H-Index

1990

Active since

Affiliations

Acadia Pharmaceuticals (United States)(Current)

Alkermes (United States)

The University of Texas Southwestern Medical Center

University of Alabama at Birmingham

Parkinson's Research and Education Foundation

Srdjan Stankovic is an author at Acadia Pharmaceuticals (United States) specializing in social sciences, psychiatry, and medicine.

ORCID

Top concepts

Publications per year

1990–2023

15

Publications

15

SUNtool – A new modelling paradigm for simulating and optimising urban sustainability

Darren Robinson, Nittaya Campbell, W. Gaiser et al. · Solar Energy · 2007 · 159 citations · Full text

, , +16

A Randomized, Double-Blind, Placebo-Controlled Trial of Aripiprazole Lauroxil in Acute Exacerbation of Schizophrenia

Herbert Y. Meltzer, Robert Risinger, Henry A. Nasrallah et al. · The Journal of Clinical Psychiatry · 2015 · 113 citations · Full text

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of Adjunctive Pimavanserin in Patients With Major Depressive Disorder and an Inadequate Response to Therapy (CLARITY)

Maurizio Fava, Bryan Dirks, Marlene P. Freeman et al. · The Journal of Clinical Psychiatry · 2019 · 49 citations · Full text

Long-term evaluation of open-label pimavanserin safety and tolerability in Parkinson's disease psychosis

Clive Ballard, David Kreitzman, Stuart Isaacson et al. · Parkinsonism & Related Disorders · 2020 · 40 citations

, , +11

Principles of climate sensitive urban design analysis in identification of suitable urban design proposals. Case study: Central zone of Leskovac competition

Aleksandra Đjukić, Milena Vukmirović, Srdjan Stankovic · Energy and Buildings · 2015 · 35 citations · Full text

, , +11

Rows per page

1–5 of 15